Important Update for Dentsply Sirona Investors
In recent news, DENTSPLY SIRONA Inc. (NASDAQ: XRAY) has found itself at the center of a class action lawsuit that could be of significant interest to its investors. Bernstein Liebhard LLP, a prominent law firm specializing in investor rights, has raised attention about this ongoing legal matter, prompting investors to take note of the critical information being outlined.
Details of the Class Action Lawsuit
The lawsuit concerns allegations of securities fraud that have been leveled against Dentsply. If you have purchased shares of DENTSPLY SIRONA between a specified period, it’s vital to understand the implications of this lawsuit and what it means for your investments.
Who Qualifies for the Class?
To determine if you qualify to be part of this class action, you should ask yourself a few key questions. Did you own shares of DENTSPLY SIRONA? Moreover, did you purchase these shares between May 6, 2021, and November 6, 2024? If so, you may have been affected by the issues leading to the lawsuit.
What Are the Allegations?
According to the allegations made in the lawsuit, Dentsply may have misrepresented the growth potential of its aligner solutions, specifically its Byte clear aligners. Investors claim that these misrepresentations affected their investment decisions and led to financial losses.
Steps to Take as an Investor
It’s essential for individuals impacted by these events to consider their next steps. Bernstein Liebhard LLP encourages those who feel they may be affected to discuss their legal rights and options. If you wish to act, ensure you file necessary legal documents by the deadline set for January 27, 2025, if you want to serve as a lead plaintiff in this case.
Your Role as a Lead Plaintiff
Being a lead plaintiff means taking a proactive stance in this lawsuit and representing the interests of other class members. While it’s not required to serve as lead plaintiff to share in any recovery from the case, participating may give you a voice in the litigation process.
Legal Representation and Costs
Furthermore, shareholders should note that representation in this case comes without upfront costs. Bernstein Liebhard LLP assures stakeholders that all fees and expenses are on a contingency basis, meaning they only get paid if you win the case.
Investor Relations Contact Information
For additional information or guidance, investors can reach out to Peter Allocco, Investor Relations Manager at Bernstein Liebhard LLP. Available via phone at (212) 951-2030, he can provide insights about the class action and help shareholders navigate their options in this situation. You can also find further details on the firm’s website.
Frequently Asked Questions
What is the purpose of the class action lawsuit involving Dentsply Sirona?
The lawsuit addresses allegations of securities fraud, claiming that Dentsply misrepresented growth prospects of its aligner business, impacting investor decisions.
How can I check if I'm eligible to join the class action?
If you owned shares of Dentsply Sirona between May 6, 2021, and November 6, 2024, you may be eligible to join the class action.
What should I do if I want to participate in the lawsuit?
Interested investors should file the necessary documentation by the deadline of January 27, 2025, if they wish to be a lead plaintiff.
What costs are involved if I participate in this class action?
There are no upfront costs for shareholders; legal representation is on a contingency fee basis, meaning you only pay if the case is successful.
Who can I contact for more information regarding this matter?
You can contact Peter Allocco at Bernstein Liebhard LLP by calling (212) 951-2030 for guidance and assistance.
